This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Training and development. Staff development and training programmes were largely on pause during the pandemic. However, demand for training has risen significantly since the start of this year as restrictions ease around the world. Harness technology. Embrace mobile learning.
At the beginning of his career in 2004, Dr Hughes was responsible for early clinical research at Bristol Myers-Squibb Company and then at Schering-Plough Research Institute. ” Since September 2021, Dr Hughes has been Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, based in Boston. .”
It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. When Milburn and Blair introduced competition in 2004-2008 it did start to make a difference.”
3 Patients required many injections over a long time period, and problems also arose from the galenic preparation of arsphenamide, which was insoluble in water.3 The development of antimicrobial resistance to penicillin and the development of complications in patients with diabetes, despite treatment with insulin, proved major limitations. [5]
In fact, our founder, Bill Brooks, wrote in his 2004 book, “Sales Techniques,” that sales professionals who focus on the motivators for the decision, rather than the raw needs, achieve a sale that is 11 percent higher than those who don’t. Be Patient: I find that a lot of salespeople will rush in with a value proposition. DOWNLOAD NOW.
As per the US Department of Justice, Biogen paid remuneration in the form of training and consulting fees and speaker honoraria, to induce physicians to prescribe the company’s drugs, in violation of the Anti-Kickback Statute. The company currently has three MS drugs in its pipeline.
If you’re not doing that, I always say you’re training TAs to go against you and work for your competitors. When you get somebody, the urgency is to get them trained up on a product. Get them trained on that product and put them out there. The reality is someone has to be there. Who are our top customers?
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content